Search research articles
Contact Us
Filters
Showing results (201-210 of 205) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 205 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1996
5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study
P Dufour, F Husseini, B Dreyfus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patients
P Viens, C Chabannon, P Pouillard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 10, 2001
Prognostic factors in ovarian carcinoma in complete histologic remission at second-look surgery
D. Hamid, B. Duclos, J. C. Barats, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma
L S Hofstra, G B Kristensen, P H Willemse, et al.
Cancer
|
July 1, 1981
A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis
J L Binet, A Auquier, G Dighiero, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 205) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 205 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 1, 1996
5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study
P Dufour, F Husseini, B Dreyfus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Randomized, controlled, dose-range study of Ro 25-8315 given before and after a high-dose combination chemotherapy regimen in patients with metastatic or recurrent breast cancer patients
P Viens, C Chabannon, P Pouillard, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 10, 2001
Prognostic factors in ovarian carcinoma in complete histologic remission at second-look surgery
D. Hamid, B. Duclos, J. C. Barats, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 1998
Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma
L S Hofstra, G B Kristensen, P H Willemse, et al.
Cancer
|
July 1, 1981
A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis
J L Binet, A Auquier, G Dighiero, et al.
Page
of 21